TransCode Therapeutics Inc.
RNAZ | NASDAQ
$1.76
+$0.11 (+6.67%)
At close: Sep 21, 2026, 4:00 PM ET
$1.76
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:44 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 8.38B | 12.84M | 17.81M | 2.84M | 7.37M | 11.57M | 5.81M | 1.88M | 3.35M | 4.91M | 2.77M | 7.45M | 3.57M | 1.62M | 4.97M | 8.79M | 13.44M | 16.85M | 20.83M | 22.5M | 79.57K | 98.96K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.41K | 9.41K | n/a | 9.41K | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.45K | n/a | 12.89K |
Other Long-Term Assets | n/a | 25K | -1 | 455.73K | 0 | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 111.86K | 247.65K | 0 | 235.82K | 0 | 0 | -1 | -9.45K | 890.45K | 386.52K |
Receivables | n/a | 2.3M | 3.25M | 198.3K | 176.12K | 322.44K | n/a | 11.95K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 487.88K | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 182.06K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.26B | 1.02M | 529.04K | 1.34M | 297.92K | 680.95K | 517.48K | 772.87K | 532.46K | 1.48M | 1.14M | 1.08M | 759.56K | 1.93M | 1.02M | 2.11M | 295.12K | 1.68M | 1.84M | 2.65M | 460.65K | 478.8K |
Total Current Assets | 10.64B | 16.75M | 21.98M | 4.75M | 8.24M | 13.04M | 7.09M | 3.61M | 4.39M | 6.71M | 4.46M | 9.37M | 4.89M | 4.35M | 7.38M | 11.57M | 13.92M | 18.63M | 22.73M | 25.2M | 540.22K | 577.76K |
Property-Plant & Equipment | 322.81M | 346.75K | 370.68K | 19.91K | 24.69K | 38.13K | 89.31K | 211.66K | 326.31K | 464.59K | 602.4K | 742.57K | 876.75K | 996.23K | 208.58K | 209.87K | 234.67K | 215.32K | 206.27K | 155.61K | 91.59K | 74.05K |
Goodwill & Intangibles | 140.04B | 140.04M | 140.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 140.37B | 140.42M | 140.41M | 475.63K | 24.69K | 149.99K | 201.16K | 323.52K | 438.17K | 576.45K | 714.26K | 854.43K | 988.61K | 1.24M | 208.58K | 445.69K | 234.67K | 215.32K | 206.27K | 155.61K | 982.05K | 473.46K |
Total Assets | 151.01B | 157.16M | 162.4M | 5.23M | 8.27M | 13.19M | 7.29M | 3.94M | 4.82M | 7.29M | 5.17M | 10.23M | 5.88M | 5.59M | 7.59M | 12.02M | 14.16M | 18.85M | 22.94M | 25.36M | 1.52M | 1.05M |
Account Payables | n/a | 5M | 3.12M | 2.68M | 1.36M | 2.43M | 2.58M | 1.97M | n/a | n/a | 2.33M | 4.86M | n/a | n/a | n/a | n/a | n/a | 1.75M | 2.02M | 1.98M | n/a | 753.32K |
Deferred Revenue | 63.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 27.06K | 54.31K | 81.75K | n/a | n/a | 23.54K | n/a | 23.54K | 30.53K | 220.08K | 251.81K | n/a |
Short-Term Debt | 652.41M | n/a | n/a | n/a | n/a | n/a | 38.29K | 152.48K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.68B | 128.5K | n/a | 75K | -1.36M | -2.43M | 26.11K | 46.41K | 156.63K | 0 | -2.33M | -4.86M | 81.75K | 0 | 57.82K | 3.61M | 23.54K | -1.75M | -2.02M | -1.98M | 29.27K | 35.53K |
Total Current Liabilities | 5.4B | 5.38M | 3.49M | 2.97M | 1.56M | 2.51M | 2.77M | 2.28M | 3.5M | 2.71M | 3.49M | 5.6M | 3.52M | 5.45M | 4.35M | 3.77M | 1.73M | 1.85M | 2.53M | 2.2M | 1.53M | 788.84K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.13M | 2.11M |
Other Long-Term Liabilities | 6.8B | 6.81M | 148.34M | 832.88K | 553.71K | 392K | 6.54M | n/a | n/a | 0 | n/a | n/a | n/a | 0 | n/a | n/a | 0 | n/a | n/a | n/a | 2.9M | 5.99M |
Total Long-Term Liabilities | 7.25B | 7.27M | 148.57M | 832.88K | 553.71K | 392K | 6.54M | n/a | n/a | 0 | 38.29K | 189.77K | 265.65K | 377.81K | n/a | n/a | 0 | n/a | n/a | n/a | 5.03M | 8.09M |
Total Liabilities | 12.65B | 12.64M | 152.06M | 3.8M | 2.12M | 2.9M | 9.31M | 2.28M | 3.5M | 2.71M | 3.53M | 5.79M | 3.79M | 5.83M | 4.35M | 3.77M | 1.73M | 1.85M | 2.53M | 2.2M | 6.56M | 8.88M |
Total Debt | 652.41M | n/a | n/a | n/a | n/a | n/a | 38.29K | 152.48K | 227.25K | 339.41K | 450.57K | 594.69K | 663.29K | 768.23K | n/a | n/a | n/a | n/a | n/a | n/a | 2.13M | 2.11M |
Book Value | 138.36B | 144.52M | 10.34M | 1.43M | 6.15M | 10.29M | -2.02M | 1.65M | 1.32M | 4.58M | 1.64M | 4.44M | 2.09M | -236.79K | 3.24M | 8.24M | 12.43M | 17M | 20.4M | 23.16M | -5.04M | -7.83M |
Book Value Per Share | 144.55K | 157.61 | 11.27 | 1.71 | 7.37 | 59.75 | -5.67 | 4.64 | 6.19 | 21.46 | 7.68 | 40.58 | 68.62 | -7.77 | 106.27 | 508.24 | 766.18 | 1.05K | 1.26K | 1.61K | -336.68 | -524.04 |
Common Stock | 101K | 92 | 92 | 84 | 84 | 2.33K | 103 | 1.73K | 727 | 581 | 63 | 1.07K | 195 | 1.58K | 2 | 1.3K | 1.3K | 1.3K | 1.29K | 1.29K | 464 | 464 |
Retained Earnings | -122.4B | -115.65M | -97.86M | -84.42M | -79.56M | -75.29M | -63.2M | -57.26M | -54.93M | -49.74M | -46.42M | -42.33M | -37.03M | -32.69M | -27.87M | -22.74M | -18.45M | -13.78M | -10.31M | -7.51M | -5.18M | -7.95M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | 0 | n/a | n/a | 0 | 0 | -9.45K | n/a | n/a |
Shareholders Equity | -27.69B | 144.52M | 10.34M | 1.43M | 6.15M | 10.29M | -2.02M | 1.65M | 1.32M | 4.58M | 1.64M | 4.44M | 2.09M | -236.79K | 3.24M | 8.24M | 12.43M | 17M | 20.4M | 23.16M | -5.04M | -7.83M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.41K | 9.41K | n/a | 9.41K | n/a | n/a | 9.45K | n/a | 12.89K |
Add to Watchlist
Select watchlists to add or remove RNAZ